This inventor holds 2 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Pharma Mar, S.a.. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2015
Title: Isabel Digón Juárez: Innovator in Antitumoral Compounds
Introduction
Isabel Digón Juárez is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of cancer treatment through her innovative research and development of antitumoral compounds. With a total of 2 patents to her name, her work is paving the way for new therapeutic options in oncology.
Latest Patents
Isabel's latest patents focus on antitumoral compounds that utilize a general formula for the treatment of cancer. The first patent describes a compound of general formula (I) wherein A, Y, W, R, R, R, R, R, and R take various meanings for use in the treatment of cancer. The second patent also details a compound of general formula (I) with similar applications, emphasizing the versatility and potential of her discoveries in combating cancer.
Career Highlights
Isabel is currently associated with Pharma Mar, S.A., a company known for its commitment to developing innovative therapies for cancer treatment. Her work at Pharma Mar has allowed her to focus on groundbreaking research that has the potential to change the landscape of cancer therapies.
Collaborations
Isabel collaborates with esteemed colleagues such as Alberto Rodríguez Vicente and Carmen Murcia Pérez. These partnerships enhance her research efforts and contribute to the advancement of their shared goals in cancer treatment.
Conclusion
Isabel Digón Juárez is a trailblazer in the field of antitumoral research, with her patents reflecting her dedication to improving cancer therapies. Her contributions are vital in the ongoing fight against cancer, and her work continues to inspire future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
